Mediators of chronic obstructive pulmonary disease

Pharmacological Reviews

Volumn 56, Issue 4, 2004, Pages 515-548

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID; ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; ANTIOXIDANT; BOSENTAN; CYSTEINE PROTEINASE INHIBITOR; EBSELEN; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROMYCIN; FLURITHROMYCIN; GEFITINIB; INDOMETACIN; INTERLEUKIN 8 ANTIBODY; LEUKOCYTE ELASTASE INHIBITOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; MIDESTEINE; MONTELUKAST; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SERATRODAST; TACHYKININ RECEPTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

APOPTOSIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DENDRITIC CELL; DISEASE EXACERBATION; EOSINOPHIL; EPITHELIUM CELL; HUMAN; INFECTION; INFECTION SENSITIVITY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; META ANALYSIS; MUCUS GLAND; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CHRONIC DISEASE; CLINICAL TRIALS; DRUG THERAPY; HUMANS; INFLAMMATION MEDIATORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 10644266789     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.56.4.2     Document Type: Review

References (445)

1. Aarbiou J, Rabe KF, and Hiemstra PS (2002) Role of defensins in inflammatory lung disease. Ann Med 34:96-101.
2. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, and Dales RE (2001) Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:349-355.
3. Adcock IM, Brown CR, Kwon OJ, and Barnes PJ (1994) Oxidative stress induces NF-κB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 199:1518-1524.
4. Adler KB, Holden Stauffer WJ, and Repine JE (1990) Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J Clin Investig 85:75-85.
5. Adler KB and Li Y (2001) Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion. Am J Respir Cell Mol Biol 25:397-400.
6. + T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med 162:1466-1473.
7. Agusti AG., Villaverde JM, Togores B, and Bosch M (1999) Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 14:523-528.
8. Aldonyte R, Jansson L, Piitulainen E, and Janciauskiene S (2003) Circulating monocytes from healthy individuals and COPD patients. Respir Res 4:11.
9. Au BT, Teixeira MM, Collins PD, and Williams TJ (1998) Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol. Br J Pharmacol 123:1260-1266.
10. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, and Hogg JC (1994) Transforming growth factor β1 gene expression in human airways. Thorax 49:225-232.
11. Avissar N, Finkelstein JN, Horowitz S, Willey JC, Coy E, Frampton MW, Watkins RH, Khullar P, Xu YL, and Cohen HJ (1996) Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. Am J Physiol 270:L173-L182.
12. Bacakoglu F, Atasever A, Ozhan MH, Gurgun C, Ozkilic H, and Guzelant A (2003) Plasma and bronchoalveolar lavage fluid levels of endothelin-1 in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Respiration 70:594-599.
13. Balbi B, Bason C, Balleari E, Fiasella F, Pesci A, Ghio R, and Fabiano F (1997) Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J 10:846-850.
14. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, and Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
15. Banerjee D, Honeybourne D, and Khair OA (2004) The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial. Treat Respir Med 3:59-65.
16. Barczyk A, Pierzchala W, and Sozanska E (2003) Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 97:726-733.
17. Barnes PJ (1992) Bradykinin and asthma. Thorax 47:979-983.
18. Barnes PJ (2000a) Chronic obstructive pulmonary disease. N Engl J Med 343:269-280.
19. Barnes PJ (2000b) Mechanisms in COPD: differences from asthma. Chest 117 (Suppl):10S-14S.
20. Barnes PJ (2001a) Cytokine modulators as novel therapies for airway disease. Eur Respir J Suppl 18:67S-77S.
21. Barnes PJ (2001b) IL-10: a key regulator of allergic disease. Clin Exp Allergy 31:667-669.
22. Barnes PJ (2001c) New treatments for chronic obstructive pulmonary disease. Curr Opin Pharmacol 1:217-222.
23. Barnes PJ (2002a) Current and future therapies for airway mucus hypersecretion. Novartis Found Symp 248:237-249.
24. Barnes PJ (2002b) New treatments for COPD. Nat Rev Drug Discov 1:437-446.
25. Barnes PJ (2003) New concepts in COPD. Annu Rev Med 54:113-129.
26. Barnes PJ (2004) Macrophages as orchestrators of COPD. J COPD 1:59-70.
27. Barnes PJ, Chung KF, and Page CP (1998) Inflammatory mediators of asthma: an update. Pharmacol Rev 50:515-596.
28. Barnes PJ, Ito K, and Adcock IM (2004) A mechanism of corticosteroid resistance in COPD: inactivation of histone deacetylase. Lancet 363:731-733.
29. Barnes PJ and Karin M (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
30. Barnes PJ, Shapiro SD, and Pauwels RA (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22:672-688.
31. Basbaum C, Li D, Gensch E, Gallup M, and Lemjabbar H (2002) Mechanisms by which gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR). Novartis Found Symp 248:171-176.
32. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, and Baggiolini M (1991) Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 173:771-774.
33. Beckman JS and Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly. Am J Physiol 271:C1432-C1437.
34. Beeh KM, Beier J, Kornmann O, and Buhl R (2003a) Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1 and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med 97:634-639.
35. Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, and Buhl R (2003b) A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 33:475-482.
36. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, and Barnes PJ (2003c) Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123:1240-1247.
37. Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, and Shapiro SD (1998) Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 4:615-618.
38. Belvisi MG and Bottomley KM (2003) The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm Res 52:95-100.
39. 1 in community-based older volunteers with higher levels of neutrophil elastase in bronchoalveolar lavage fluid. Respiration 67:261-267.
40. Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Venge P, Xu S, and Kawakami Y (1999) Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 159:1985-1991.
41. Bhowmik A, Seemungal TA, Sapsford EJ, and Wedzicha JA (2000) Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 55:114-120.
42. 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 58:294-298.
43. Bocchino V, Bertorelli G, Bertrand CP, Ponath PD, Newman W, Franco C, Marruchella A, Merlini S, Del Donno M, Zhuo X, et al. (2002) Eotaxin and CCR3 are up-regulated in exacerbations of chronic bronchitis. Allergy 57:17-22.
44. Borchers MT, Carty MP, and Leikauf GD (1999) Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol 276:L549-L555.
45. Bowler RP and Crapo JD (2002) Oxidative stress in airways: is there a role for extracellular superoxide dismutase? Am J Respir Crit Care Med 166:S38-S43.
46. Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, and Butcher EC (1998) Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J Biol Chem 273:28040-28048.
47. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, and Pavord ID (2000) Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356:1480-1485.
48. Britton JR, Pavord ID, Richards KA, Knox AJ, Wisniewski AF, Lewis SA, Tattersfield AE, and Weiss ST (1995) Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 151:1383-1387.
49. Brunelleschi S, Guidotto S, Viano I, Fantozzi R, Pozzi E, Ghio P, and Albera C (1996) Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study. Neuropeptides 30:456-464.
50. Bucchioni E, Kharitonov SA, Allegra L, and Barnes PJ (2003) High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 97:1299-1302.
51. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, and Maslen T (2000) Randomised, double-blind, placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease; the ISOLDE trial. BMJ 320:1297-1303.
52. Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, and Atik U (2004) Leptin and TNF-α levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration 71:45-50.
53. Calikoglu M, Unlu A, Tamer L, Ercan B, Bugdayci R, and Atik U (2002) The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med 40:1028-1031.
54. Campbell EJ, Campbell MA, and Owen CA (2000) Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity and susceptibility to inhibition. J Immunol 165:3366-3374.
55. Cantin AM, Fells GA, Hubbard RC, and Crystal RG (1990) Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Investig 86:962-971.
56. Capelli A, Di Stefano A, Gnemmi I, Balbo P, Cerutti CG, Balbi B, Lusuardi M, and Donner CF (1999) Increased MCP-1 and MIP-1β in bronchoalveolar lavage fluid of chronic bronchitis. Eur Respir J 14:160-165.
57. Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P, Fan CK, Barnes PJ, Adcock IM, Ciaccia A, et al. (2003) Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 58:348-351.
58. Carp H and Janoff A (1978) Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 118:617-621.
59. Carrell RW and Lomas DA (2002) α1-Antitrypsin deficiency - a model for conformational diseases. N Engl J Med 348:45-53.
60. Carter AB, Monick MM, and Hunninghake GW (1998) Lipopolysaccharide- induced NF-κB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC- dependent. Am J Respir Cell Mol Biol 18:384-391.
61. Casolaro MA, Bernaudin JF, Saltini C, Ferrans VJ, and Crystal RG (1988) Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 137:406-411.
62. Cataldo D, Munaut C, Noel A, Frankenne F, Bartsch P, Foidart JM, and Louis R (2000) MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123:259-267.
63. Cawston T, Carrere S, Catterall J, Duggleby R, Elliott S, Shingleton B, and Rowan A (2001) Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found Symp 234:205-218.
64. Chalmers GW, Macleod KJ, Sriram S, Thomson LJ, McSharry C, Stack BH, and Thomson NC (1999) Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. Eur Respir J 13:1288-1292.
65. Chapman HA, Riese RJ, and Shi GP (1997) Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88.
66. Chodniewicz D and Zhelev DV (2003) Novel pathways of F-actin polymerization in the human neutrophil. Blood 102:2251-2258.
67. Choi AM and Alam J (1996) Heme oxygenase-1: function, regulation and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15:9-19.
68. Chung KF (2001) Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 34:50s-59s.
69. Chung KF and Barnes PJ (1999) Cytokines in asthma. Thorax 54:825-857.
70. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, Shapiro SD, and Wright JL (2003) Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release. Am J Respir Crit Care Med 167:1083-1089.
71. Churg A, Wang RD, Tai H, Wang X, Xie C, and Wright JL (2004) Tumor necrosis factor-α drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 170:492-498.
72. Clark-Lewis I, Mattioli I, Gong JH, and Loetscher P (2003) Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J Biol Chem 278:289-295.
73. Comhair SA and Erzurum SC (2002) Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 283:L246-L255.
74. Condliffe AM, Kitchen E, and Chilvers ER (1998) Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 94:461-471.
75. Corradi M, Majori M, Cacciani GC, Consigli GF, de'Munari E, and Pesci A (1999) Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 54:572-575.
76. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, and Barnes PJ (2001) Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 163:854-858.
77. Corradi M, Rubinstein I, Andreoli R, Manini P, Caglieri A, Poli D, Alinovi R, and Mutti A (2003) Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1380-1386.
78. Cosio MG, Majo J, and Cosio MG (2002) Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 121 (Suppl):160S-165S.
79. 4. Eur Respir J 15:274-280.
80. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, and Barnes PJ (2002) Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 166:1345-1349.
81. Culpitt SV, Nightingale JA, and Barnes PJ (1999) Effect of high dose inhaled steroid on cells, cytokines and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1635-1639.
82. Culpitt SV, Rogers DF, Shah P, de Matos C, Russell RE, Donnelly LE, and Barnes PJ (2003) Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:24-31.
83. Cuzzocrea S, Riley DP, Caputi AP, and Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation and ischemia/reperfusion injury. Pharmacol Rev 53:135-159.
84. DaCosta BS, Major C, Laping NJ, and Roberts AB (2004) SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5 and ALK7. Mol Pharmacol 65:744-752.
85. Dallas SL, Rosser JL, Mundy GR, and Bonewald LF (2002) Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-β from bone matrix. J Biol Chem 277:21352-21360.
86. Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, Fallahnejad M, and Weinbaum G (1986) Immunolocalization of elastase in human emphysematous lungs. J Clin Investig 78:482-493.
87. Davi G, Basili S, Vieri M, Cipollone F, Santarone S, Alessandri C, Gazzaniga P, Cordova C, and Violi F (1997) Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:1794-1799.
88. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, Leblanc P, and Maltais F (2003) Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 124:83-89.
89. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, and Hiemstra PS (2000) Monocyte chemoattractant protein 1, interleukin 8 and chronic airways inflammation in COPD. J Pathol 190:619-626.
90. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, and van Krieken JH (1998) Transforming growth factor β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:1951-1957.
91. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, and Remick DG (1993) Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 268:25568-25576.
92. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, and Rogers RM (1996) Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 153:633-637.
93. de Jong JW, Belt-Gritter B, Koeter GH, and Postma DS (1997) Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir Med 91:67-76.
94. Dekhuijzen PNR, Aben KHH, Dekker I, Aarts LPHJ, Wielders PLM, van Herwarden CLA, and Bast A (1996) Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:813-816.
95. Demoly P, Simony-Lafontaine J, Chanez P, Pujol JL, Lequeux N, Michel FB, and Bousquet J (1994) Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics. Am J Respir Crit Care Med 150:214-217.
96. D'Hulst A, Vermeulen KY, and Pauwels RA (2002) Cigarette smoke exposure causes increase in pulmonary dendritic cells. Am J Respir Crit Care Med 164:A604.
97. Di Francia M, Barbier D, Mege JL, and Orehek J (1994) Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455.
98. DiMango E, Ratner AJ, Bryan R, Tabibi S, and Prince A (1998) Activation of NF-κB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Investig 101:2598-2605.
99. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, and Saetta M (1998) Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 158:1277-1285.
100. Di Stefano A, Caramori G, Capelli A, Gnemmi I, Ricciardolo F, Oates T, Donner CF, Chung KF, Barnes PJ, and Adcock IM (2004) STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 24:78-85.
101. Di Stefano A, Caramori G, Capelli A, Lusuardi M, Gnemmi I, Ioli F, Chung KF, Donner CF, Barnes PJ, and Adcock IM (2002) Increased expression of NF-κB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 20:556-563.
102. Di Stefano A, Maestrelli P, Roggeri A, Turato G, Calabro S, Potena A, Mapp CE, Ciaccia A, Covacev L, and Fabbri LM (1994) Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149:803-810.
103. Duranton J and Bieth JG (2003) Inhibition of proteinase 3 by [α]1-antitrypsin in vitro predicts very fast inhibition in vivo. Am J Respir Cell Mol Biol 29:57-61.
104. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and van der Vliet A (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (Lond) 391:393-397.
105. Fabbri L, Beghe B, Caramori G, Papi A, and Saetta M (1998) Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax 53:803-808.
106. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, and Papi A (2003) Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:418-424.
107. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, and Henson PM (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (Lond) 405:85-90.
108. Faller M, Kessler R, Sapin R, Chaouat A, Ehrhart M, Ducolone A, and Weitzenblum E (1998) Regulation of endothelin-1 at rest and during a short steady-state exercise in 21 COPD patients. Pulm Pharmacol Ther 11:151-157.
109. Farshid AA, Sadeghi-Hashjin G, and Ferdowsi HR (2002) Histopathological studies on the effects of peroxynitrite on the lungs and trachea of rabbits. Eur Respir J 20:1014-1016.
110. Ferrarotti I, Zorzetto M, Beccaria M, Gile LS, Porta R, Ambrosino N, Pignatti PF, Cerveri I, Pozzi E, and Luisetti M (2003) Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur Respir J 21:444-449.
111. Finkelstein R, Fraser RS, Ghezzo H, and Cosio MG (1995) Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152:1666-1672.
112. Finlay GA, O'Driscoll LR, Russell KJ, D'Arcy EM, Masterson JB, FitzGerald MX, and O'Connor CM (1997) Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156:240-247.
113. Fischer B and Voynow J (2000) Neutrophil elastase induces MUC5AC messenger RNA expression by an oxidant-dependent mechanism. Chest 117 (Suppl 1):317S-320S.
114. Fischer BM and Voynow JA (2002) Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 26:447-452.
115. Floreani AA, Wyatt TA, Stoner J, Sanderson SD, Thompson EG, Allen-Gipson D, and Heires AJ (2003) Smoke and C5a induce airway epithelial ICAM-1 and cell adhesion. Am J Respir Cell Mol Biol 29:472-482.
116. Forman HJ and Torres M (2002) Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166:S4-S8.
117. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, and Barnes PJ (1996) Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nat Med 2:814-817.
118. Francus T, Klein RF, Staiano-Coico L, Becker CG, and Siskind GW (1988) Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol 140:1823-1829.
119. Franklin WA, Veve R, Hirsch FR, Helfrich BA, and Bunn Jr PA (2002) Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol 29:3-14.
120. Fujimoto K, Imaizumi T, Yoshida H, Takanashi S, Okumura K, and Satoh K (2001) Interferon-γ stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. Am J Respir Cell Mol Biol 25:233-238.
121. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, and Heinecke JW (2002) Myeloperoxidase produces nitrating oxidants in vivo. J Clin Investig 109:1311-1319.
122. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, and Gordon JL (1994) Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature (Lond) 370:555-557.
123. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, and Baggiolini M (1993) The interleukin-8-related chemotactic cytokines GROα, GROβ and GROγ activate human neutrophil and basophil leukocytes. J Biol Chem 268:15419-15424.
124. Germonpre PH, Bullock GR, Lambrecht BN, Van De Velde V, Luyten WH, Joos GF, and Pauwels RA (1999) Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 14:776-782.
125. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib M, Kimura S, Masaki T, Duguid W, and Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328:1732-1739.
126. Godoy I, Campana AO, Geraldo RR, Padovani CR, and Paiva SA (2003) Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients. Eur Respir J 22:920-925.
127. Gompertz S, O'Brien C, Bayley DL, Hill SL, and Stockley RA (2001) Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 17:1112-1119.
128. Gorrini M, Lupi A, Viglio S, Pamparana F, Cetta G, Iadarola P, Powers JC, and Luisetti M (2001) Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. Am J Respir Cell Mol Biol 25:492-499.
129. Goswami SK, Kivity S, and Marom Z (1990) Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis 141:72-78.
130. Gotoh Y and Cooper JA (1998) Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction. J Biol Chem 273:17477-17482.
131. Gottlieb DJ, Stone PJ, Sparrow D, Gale ME, Weiss ST, Snider GL, and O'Connor GT (1996) Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med 154:1290-1295.
132. Grandjean EM, Berthet P, Ruffmann R, and Leuenberger P (2000) Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther 22:209-221.
133. Gutierrez-Ramos JC, Lloyd C, Kapsenberg ML, Gonzalo JA, and Coyle AJ (2000) Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung. Immunol Rev 177:31-42.
134. 2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-α: modulation by dexamethasone. Mol Pharmacol 57:1123-1131.
135. Haddad J (2004) Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment. Int Immunopharmacol 4:475-493.
136. Hageman GJ, Larik I, Pennings HJ, Haenen GR, Wouters EF, and Bast A (2003) Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation and oxidative stress in COPD patients. Free Radic Biol Med 35:140-148.
137. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, and Barnes PJ (2003) A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 17:1298-1300.
138. Hardaker EL, Bacon AM, Carlson K, Roshak AIC, Foley JJ, Schmidt DB, Buckley PT, Comegys M, Panettieri Jr RA, Sarau HM, et al. (2004) Regulation of TNF-α and IFN-γ induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. FASEB J 18:191-193.
139. Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, and Nakajima H (2000) Upregulation of two death pathways of perform/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 161:237-243.
140. Hautamaki RD, Kobayashi DK, Senior RM, and Shapiro SD (1997) Requirement for macrophage metalloelastase for cigarette smoke-induced emphysema in mice. Science (Wash DC) 277:2002-2004.
141. Hay DWP and Sarau HM (2001) Interleukin-8 receptor antagonists in pulmonary diseases. Curr Opin Pharmacol 1:242-247.
142. Hellermann GR, Nagy SB, Kong X, Lockey RF, and Mohapatra SS (2002) Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res 3:22-28.
143. Henricks PA and Nijkamp FP (2001) Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 14:409-420.
144. Higham MA, Pride NB, Alikhan A, and Morrell NW (2000) Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 15:281-284.
145. Hill AT, Bayley D, and Stockley RA (1999) The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 160:893-898.
146. Hill AT, Campbell EJ, Hill SL, Bayley DL, and Stockley RA (2000) Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109:288-295.
147. Hirano K, Sakamoto T, Uchida Y, Morishima Y, Masuyama K, Ishii Y, Nomura A, Ohtsuka M, and Sekizawa K (2001) Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 18:748-752.
148. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, and Holmes M (2003) Increased production of TGF-β and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 285:L492-L499.
149. Hogg JC, Utokaparch S, Yamada Y, Elliott WM, Buzatu L, and Cherniack RM (2004) The nature of small airway obstruction in chronic pulmonary obstructive disease. N Engl J Med 350:2645-2653.
150. Hogg JC and Walker BA (1995) Polymorphonuclear leucocyte traffic in lung inflammation. Thorax 50:819-820.
151. Hokuto I, Perl AK, and Whitsett JA (2003) Prenatal, but not postnatal, inhibition of fibroblast growth factor receptor signaling causes emphysema. J Biol Chem 278:415-421.
152. Holt PG and Stumbles PA (2000) Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J Allergy Clin Immunol 105:421-429.
153. Horiguchi T, Tachikawa S, Kondo R, Shiga M, Hirose M, and Fukumoto K (2002) Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. Arzneim-Forsch 52:764-768.
154. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, and Hacohen N (2001) The plasticity of dendritic cell responses to pathogens and their components. Science (Wash DC) 294:870-875.
155. Huang SL, Su CH, and Chang SC (1997) Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156:1436-1439.
156. 2 and thromboxane receptors. Am J Respir Crit Care Med 150:1012-1018.
157. Hutchison KA, Matic G, Meshinchi S, Bresnick EH, and Pratt WB (1991) Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. J Biol Chem 266:10505-10509.
158. Huynh ML, Fadok VA, and Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Investig 109:41-50.
159. Ichinose M, Sugiura H, Yamagata S, Koarai A, and Shirato K (2000) Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 160:701-706.
160. Ihn H (2002) Pathogenesis of fibrosis: role of TGF-β and CTGF. Curr Opin Rheumatol 14:681-685.
161. Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, and D'Armiento J (2001) Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163:786-791.
162. Imaizumi T, Albertine KH, Jicha DL, McIntyre TM, Prescott SM, and Zimmerman GA (1997) Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. Am J Respir Cell Mol Biol 17:181-192.
163. Ishii T, Matsuse T, Teramoto S, Matsui H, Hosoi T, Fukuchi Y, and Ouchi Y (2000a) Association between α1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur J Clin Investig 30:543-548.
164. Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, and Ouchi Y (2000b) Neither IL-1β, IL-1 receptor antagonist, nor TNF-α polymorphisms are associated with susceptibility to COPD. Respir Med 94:847-851.
165. Ishikawa T, Kume H, Kondo M, Ito Y, Yamaki K, and Shimokata K (2003) Inhibitory effects of interferon-γ on the heterologous desensitization of β-adrenoceptors by transforming growth factor-β1 in tracheal smooth muscle. Clin Exp Allergy 33:808-815.
166. 4 acetylation on lysines 8 and 12. Mol Cell Biol 20:6891-6903.
167. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, and Adcock IM (2001a) Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 15:1100-1102.
168. Ito K, Tomita T, Barnes PJ, and Adcock IM (2004) Oxidative stress reduces histone deacetylase (HDAC)2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315:240-245.
169. Ito K, Watanabe S, Kharitonov S, Hanazawa T, Adcock IM, and Barnes PJ (2001b) Histone deacetylase activity and gene expression in COPD patients. Eur Respir J 18:316S.
170. Janssen-Heininger YM, Poynter ME, and Baeuerle PA (2000) Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 28:1317-1327.
171. Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067-L1082.
172. Jazrawi E, Cosio BG, Barnes PJ, and Adcock IM (2003) Inhibition of IKK2 and JNK differentially regulates GM-CSF and IL-8 release in epithelial cells and alveolar macrophages. Am J Respir Crit Care Med 167:A798.
173. Jiang YJ, Lu B, Choy PC, and Hatch GM (2003) Regulation of cytosolic phospholipase A2, cyclooxygenase-1 and -2 expression by PMA, TNFα, LPS and M-CSF in human monocytes and macrophages. Mol Cell Biochem 246:31-38.
174. Jin FY, Nathan C, Radzioch D, and Ding A (1997) Secretory leukocyte protease inhibitor, a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88:417-426.
175. Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, and Hunninghake GW (1998) Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 160:6172-6181.
176. Jones CE and Chan K (2002) Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α and granulocyte-colony- stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 26:748-753.
177. Jones KL, Bryan TW, Jinkins PA, Simpson KL, Grisham MB, Owens MW, Milligan SA, Markewitz BA, and Robbins RA (1998) Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am J Physiol 275:L1120-L1126.
178. Joos GF and Pauwels RA (2001) Tachykinin receptor antagonists: potential in airways diseases. Curr Opin Pharmacol 1:235-241.
179. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, and Sandford AJ (2002) The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 11:569-576.
180. Kanazawa H, Asai K, Hirata K, and Yoshikawa J (2003a) Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 114:354-358.
181. Kanazawa H, Hirata K, and Yoshikawa J (2003b) Imbalance between vascular endothelial growth factor and endostatin in emphysema. Eur Respir J 22:609-612.
182. Kanazawa H, Shiraishi S, Hirata K, and Yoshikawa J (2003c) Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease. Thorax 58:106-109.
183. Kang MJ, Oh YM, Lee JC, Kim DG, Park MJ, Lee MG, Hyun IG, Han SK, Shim YS, and Jung KS (2003) Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow. J Korean Med Sci 18:821-827.
184. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, and Voelkel NF (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Investig 106:1311-1319.
185. 2α, a novel non-cyclooxygenase derived prostaglandin, is a potent constrictor of guinea-pig and human airways. Am J Respir Crit Care Med 153:590-596.
186. Keatings VM and Barnes PJ (1997) Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma and normal subjects. Am J Respir Crit Care Med 155:449-453.
187. Keatings VM, Cave SJ, Henry MJ, Morgan K, O'Connor CM, FitzGerald MX, and Kalsheker N (2000) A polymorphism in the tumor necrosis factor-α gene promoter region may predispose to a poor prognosis in COPD. Chest 118:971-975.
188. Keatings VM, Collins PD, Scott DM, and Barnes PJ (1996) Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153:530-534.
189. Keatings VM, Jatakanon A, Worsdell YM, and Barnes PJ (1997) Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155:542-548.
190. Kenyon KW and Nappi JM (2003) Bosentan for the treatment of pulmonary arterial hypertension. Ann Pharmacother 37:1055-1062.
191. Kharitonov SA and Barnes PJ (2001) Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693-1772.
192. Killingsworth CR, Shore SA, Alessandrini F, Dey RD, and Paulauskis JD (1997) Rat alveolar macrophages express preprotachykinin gene-I mRNA- encoding tachykinins. Am J Physiol 273:L1073-L1081.
193. Kim WD, Kim WS, Koh Y, Lee SD, Lim CM, Kim DS, and Cho YJ (2002) Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest 122:437-444.
194. Kokturk N, Tatlicioglu T, Memis L, Akyurek N, and Akyol G (2003) Expression of transforming growth factor β1 in bronchial biopsies in asthma and COPD. J Asthma 40:887-893.
195. Kranenburg AR, de Boer WI, van Krieken JH, Mooi WJ, Walters JE, Saxena PR, Sterk PJ, and Sharma HS (2002) Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 27:517-525.
196. Kroeger KM, Steer JH, Joyce DA, and Abraham LJ (2000) Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 12:110-119.
197. Kucukaycan M, Van Krugten M, Pennings HJ, Huizinga TW, Buurman WA, Dentener MA, and Wouters EF (2002) Tumor necrosis factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 3:29.
198. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, and Suda T (1998) Regulation of matrix metalloproteinases (MMP-2, -3, -9 and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139:1338-1345.
199. Kwon OJ, Au BT, Collins PD, Adcock IM, Mak JC, Robbins RA, Baraniuk JM, Chung KF, and Barnes PJ (1994) Tumor necrosis factor-induced interleukin 8 expression in cultured human epithelial cells. Am J Physiol 11:L398-L405.
200. Lacoste JY, Bousquet J, and Chanez P (1993) Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis and chronic obstructive pulmonary disease. J Allergy Clin Immunol 92:537-548.
201. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, and Dayer JM (1995) IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Investig 96:2304-2310.
202. Langen RC, Korn SH, and Wouters EF (2003) ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 35:226-235.
203. Langen RC, Schols AM, Kelders MC, Wouters EF, and Janssen-Heininger YM (2001) Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB. FASEB J 15:1169-1180.
204. Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B, Chen Q, Homer RJ, Wang J, Rabach LA, et al. (2002) Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Investig 110:463-474.
205. Le Barillec K, Si-Tahar M, Balloy V, and Chignard M (1999) Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation. J Clin Investig 103:1039-1046.
206. Leckie MJ, Jenhins GR, Khan J, Smith SJ, Walker C, Barnes PJ, and Hansel TT (2003) Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax 58:23-29.
207. Lee E, Robertson T, Smith J, and Kilfeather S (2000) Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med 161:1881-1886.
208. Lee LY, Kwong K, Lin YS, and Gu Q (2002) Hypersensitivity of bronchopulmonary C-fibers induced by airway mucosal inflammation: cellular mechanisms. Pulm Pharmacol Ther 15:199-204.
209. Lei Y-H, Barnes PJ, and Rogers DF (1996) Involvement of hydroxyl radicals in neurogenic airway plasma exudation and bronchoconstriction in guinea pigs in vivo. Br J Pharmacol 117:449-454.
210. Lim S, Groneberg D, Fischer A, Oates T, Caramori G, Mattos W, Adcock I, Barnes PJ, and Chung KF (2000a) Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways. Effect of inhaled corticosteroids. Am J Respir Crit Care Med 162:1912-1918.
211. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, and Fan CK (2000b) Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 162:1355-1360.
212. + T-lymphocytes. FEBS Lett 405:253-259.
213. Liu H, Lazarus SC, Caughey GH, and Fahy JV (1999) Neutrophil elastase and elastase-rieh cystic fibrosis sputum degranulate human eosinophils in vitro. Am. J Physiol 276:L28-L34.
214. Lloyd CM, Delaney T, Nguyen T, Tian J, Martinez A, Coyle AJ, and Gutierrez-Ramos JC (2000) CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 191:265-274.
215. Lomas DA and Mahadeva R (2002) α1-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Investig 110:1585-1590.
216. Lopez AD and Murray CC (1998) The global burden of disease, 1990-2020. Nat Med 4:1241-1243.
217. Lucey EC, Keane J, Kuang PP, Snider GL, and Goldstein RH (2002) Severity of elastase-induced emphysema is decreased in tumor necrosis factor-α and interleukin-1β receptor-deficient mice. Lab Investig 82:79-85.
218. Luisetti M, Sturani C, Sella D, Madonini E, Galavotti V, Bruno G, Peona V, Kucich U, Dagnino G, Rosenbloom J, et al. (1996) MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur Respir J 9:1482-1486.
219. Lukacs NW (2001) Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1:108-116.
220. Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902-1909.
221. MacNee W (2000) Oxidants/antioxidants and COPD. Chest 117 (Suppl 1):303S-317S.
222. MacNee W (2001) Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429:195-207.
223. MacNee W, Wiggs B, Belzberg AS, and Hogg JC (1989) The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 321:924-928.
224. Maestrelli P, Paska A, Saetta M, Turato G, Nowicki Y, Monti S, Formichi B, Miniati M, and Fabbri LM (2003) Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 21:971-976.
225. Mahadeva R and Lomas DA (1998) Genetics and respiratory disease. 2. α1-Antitrypsin deficiency, cirrhosis and emphysema. Thorax 53:501-505.
226. Majo J, Ghezzo H, and Cosio MG (2001b) Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 17:946-953.
227. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, and Pesci A (1999) Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 103:458-462.
228. 2-adrenoceptor gene transcription. Naunyn Schmiedebergs Arch Pharmacol 362:520-525.
229. Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, and Roth MD (2003) All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 124:1724-1732.
230. Mapp CE, Miotto D, Braccioni F, Saetta M, Turato G, Maestrelli P, Krause JE, Karpitskiy V, Boyd N, Geppetti P, et al. (2000) The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am J Respir Crit Care Med 161:207-215.
231. Marc MM, Korosec P, Kosnik M, Kern I, Flezar M, Suskovic S, and Sorli J (2004) Complement factors C3a, C4a and C5a in chronic obstructive pulmonary disease and asthma. Am J Respir Cell Mol Biol 31:216-219.
232. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, and Barnes PJ (1998) Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:998-1002.
233. 2 inhibits lipopolysaccharride-induced tumour necrosis factor-α. Br J Pharmacol 122:149-157.
234. Meshi B, Vitalis TZ, Ionescu D, Elliott WM, Liu C, Wang XD, Hayashi S, and Hogg JC (2002) Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 26:52-57.
235. Miller AL, Strieter RM, Gruber AD, Ho SB, and Lukacs NW (2003) CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J Immunol 170:3348-3356.
236. Minematsu N, Nakamura H, Tateno H, Nakajima T, and Yamaguchi K (2001) Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 289:116-119.
237. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, and Rennard SI (1997) Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 155:1770-1776.
238. Miotto D, Ruggieri MP, Boschetto P, Cavallesco G, Papi A, Bononi I, Piola C, Murer B, Fabbri LM, and Mapp CE (2003) Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J 22:602-608.
239. Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, McCarley D, Mulkins M, Weatherhead GS, Lapierre JM, Dankwardt J, et al. (2000) Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem 275:25562-25571.
240. Montuschi P and Barnes PJ (2002a) Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 23:232-237.
241. Montuschi P and Barnes PJ (2002b) Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 109:615-620.
242. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, and Barnes PJ (2000) Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162:1175-1177.
243. Montuschi P, Kharitonov SA, and Barnes PJ (2001) Exhaled carbon monoxide and nitric oxide in COPD. Chest 120:496-501.
244. Montuschi P, Kharitonov SA, Ciabattoni G, and Barnes PJ (2003) Exhaled leukotrienes and prostaglandins in COPD. Thorax 58:585-588.
245. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, and Sheppard D (2003) Loss of integrin αv β6-mediated TGF-β activation causes MMP12-dependent emphysema. Nature (Lond) 422:169-173.
246. Morrison D, Strieter RM, Donnelly SC, Burdick MD, Kunkel SL, and MacNee W (1998) Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers. Eur Respir J 12:1067-1072.
247. Morrow JD (2000) The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 32:377-385.
248. Mostafa ME, Chollet-Martin S, Oudghiri M, Laquay N, Jacob MP, Michel JB, and Feldman LJ (2001) Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc Res 49:882-890.
249. Mukaida N (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol 284:L566-L577.
250. Murray CJL, Lopez AD, Mathers CD, and Stein C (2001) The Global Burden of Disease 2000 Project. Global programme on evidence for health policy discussion, paper #36. World Health Organization, Geneva, Switzerland, http:// www3.who.int/whois/burden/papers/discussion%20paper%2036%20revised.doc.
251. Nabeyrat E, Jones GE, Fenwick PS, Barnes PJ, and Donnelly LE (2003) Mitogen-activated protein kinases mediate peroxynitrite-induced cell death in human bronchial epithelial cells. Am J Physiol 284:L1112-L1120.
252. Nadel JA (1990) Decreased neutral endopeptidases: possible role in inflammatory diseases of airways. Lung 168:123-127.
253. Nadel JA (2000) Role of neutrophil elastase in hypersecretion during COPD exacerbations and proposed therapies. Chest 117 (Suppl 2):386S-389S.
254. Nadel JA and Burgel PR (2001) The role of epidermal growth factor in mucus production. Curr Opin Pharmacol 1:254-258.
255. Nagaki M, Shimura S, Irokawa T, Sasaki T, Oshiro T, Nara M, Kakuta Y, and Shirato K (1996) Bradykinin regulation of airway submucosal gland secretion: role of bradykinin receptor subtype. Am J Physiol 270:L907-L913.
256. Nagase H and Brew K (2003) Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors. Biochem Soc Symp 70:201-212.
257. Nakamura H, Yoshimura K, Jaffe HA, and Crystal RG (1991a) Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 266:19611-19617.
258. Nakamura H, Yoshimura K, Jaffe HA, and Crystal RG (1991b) Transcriptional regulation of interleukin-8 gene expression by tumor necrosis factor-x in bronchial epithelial cells. Am Rev Respir Dis 143:A201.
259. Nakamura H, Yoshimura K, McElvaney NG, and Crystal RG (1992) Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Investig 89:1478-1484.
260. 2 in pulmonary A549 cells does not involve activation of NF-κB. Biochem Biophys Res Commun 277:675-679.
261. Newton R, Kuitert LM, Bergmann M, Adcock IM, and Barnes PJ (1997) Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem Biophys Res Commun 237:28-32.
262. 2-adrenergic and anticholinergic drugs. Thorax 45:694-698.
263. Nocker RE, Schoonbrood DF, Van de Graaf EA, Hack CE, Lutter R, Jansen HM, and Out TA (1996) Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 109:183-191.
264. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, and Agusti AG (2001) Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56:432-437.
265. Nossaman BD, Dabisch PA, Liles JT, Baber SR, Champion HC, Kaye AD, Feng CJ, Anwar M, Bivalacqua TJ, Santiago JA, et al. (2004) Peroxynitrite does not impair pulmonary and systemic vascular responses. J Appl Physiol 96:455-462.
266. Nowak D, Kasielski M, Antczak A, Pietras T, and Bialasiewicz P (1999) Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93:389-396.
267. 1. Am J Respir Crit Care Med 155:852-857.
268. Ogawa E, Elliott WM, Hughes F, Eichholtz TJ, Hogg JC, and Hayashi S (2004) Latent adenoviral infection induces production of growth factors relevant to airway remodeling in COPD. Am J Physiol 286:L189-L197.
269. Ogura M and Kitamura M (1998) Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. J Immunol 161:3569-3574.
270. Ohbayashi H (2002) Neutrophil elastase inhibitors as treatment for COPD. Expert Opin Investig Drugs 11:965-980.
271. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, and Konttinen YT (1998) Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Investig 78:1077-1087.
272. Ohrui T, Sekizawa K, Yamauchi K, Ohkawara Y, Nakazawa H, Aikawa T, Sasaki H, and Takishima T (1991) Chemical oxidant potentiates electrically and acetylcholine- induced contraction in rat trachea: possible involvement of cholinesterase inhibition. J Pharmacol Exp Ther 259:371-376.
273. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, Yoshikawa N, Poellinger L, Umesono K, and Makino I (1999) Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274:10363-10371.
274. 2α induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 155:436-441.
275. Olson TS and Ley K (2002) Chemokines and cheraokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Camp Physiol 283:R7-R28.
276. Owen CA, Campbell MA, Boukedes SS, and Campbell EJ (1997) Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. Am J Physiol 272:L385-L393.
277. Owen CA, Hu Z, Barrick B, and Shapiro SD (2003) Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29:283-294.
278. Owen CA, Hu Z, Lopez-Otin C, and Shapiro SD (2004) Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 172:7791-7803.
279. + effector T cells. J Leukoc Biol 71:669-676.
280. Palladino MA, Bahjat FR, Theodorakis EA, and Moldawer LL (2003) Anti-TNF-α therapies: the next generation. Nat Rev Drug Discov 2:736-746.
281. Panina-Bordignon P and D'Ambrosio D (2003) Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 9:104-110.
282. Panzner P, Lafitte JJ, Tsicopoulos A, Hamid Q, and Tulic MK (2003) Marked up-regulation of T lymphocytes and expression of interleukin-9 in bronchial biopsies from patients with chronic bronchitis with obstruction. Chest 124:1909-1915.
283. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, and Fabbri LM (2000) Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1773-1777.
284. Paredi P, Kharitonov SA, and Barnes PJ (2002) Analysis of expired air for oxidation products. Am J Respir Crit Care Med 166:S31-S37.
285. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, and Barnes PJ (2000) Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:369-373.
286. Parker LC, Whyte MK, Vogel SN, Dower SK, and Sabroe I (2004) Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol 172:4977-4986.
287. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, and Wedzicha JA (2002) Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbations. Thorax 57:759-764.
288. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, and Ohlsson SV (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948-1953.
289. 2. Lancet 344:436-438.
290. Peleman RA, Rytila PH, Kips JC, Joos GF, and Pauwels RA (1999) The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 13:839-843.
291. Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, and Dormer CF (1998) Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 12:380-386.
292. Pettersen CA and Adler KB (2002) Airways inflammation and COPD: epithelial-neutrophil interactions. Chest 121 (Suppl):142S-150S.
293. 1 receptor activation elicits secretion from porcine airway submucosal glands. Br J Pharmacol 138:254-260.
294. Pilette C, Ouadrhiri Y, Godding V, Vaerman JP, and Sibille Y (2001) Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J 18:571-588.
295. Pinamonti S, Leis M, Barbieri A, Leoni D, Muzzoli M, Sostero S, Chicca MC, Carrieri A, Ravenna F, Fabbri LM, et al. (1998) Detection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. Free Radic Biol Med 25:771-779.
296. Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, and Patakas D (2002) Tumor necrosis factor-α serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 96:594-598.
297. Poole PJ and Black PN (2001) Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 322:1271-1274.
298. 2α-III, an index of oxidant stress. Am J Respir Crit Care Med 158:1709-1714.
299. Prause O, Laan M, Lotvall J, and Linden A (2003) Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-α- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 462:193-198.
300. Prieto A, Reyes E, Bernstein ED, Martinez B, Monserrat J, Izquierdo JL, Callol L, de Lucas P, Alvarez-Sala R, Alvarez-Sala JL, et al. (2001) Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon). Am J Respir Crit Care Med 163:1578-1583.
301. Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G, Riccobono L, Bellia V, Bousquet J, and Vignola AM (2003) Effect of cilomilast (Ariflo) on TNF-α, IL-8 and GM-CSF release by airway cells of patients with COPD. Thorax 58:573-579.
302. Proudfoot AE (2002) Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2:106-115.
303. Pryor WA and Stone K (1993) Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate and peroxynitrite. Ann NY Acad Sci 686:12-27.
304. Pulleyn LJ, Newton R, Adcock IM, and Barnes PJ (2001) TGF β1 allele association with asthma severity. Hum Genet 109:623-627.
305. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, and Weiss SJ (2000) Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 192:789-800.
306. Qiu Y, Zhu J, Bandi V, Atmar R, Hattotuwa K, Guntupalli K, and Jeffery P (2003) Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168:968-975.
307. Rabinovich RA, Figueras M, Ardite E, Carbo N, Troosters T, Filella X, Barbera JA, Fernandez-Checa JC, Argiles JM, and Roca J (2003) Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 21:789-794.
308. Rabinowitz MH, Andrews RC, Becherer JD, Bickett DM, Bubacz DG, Conway JG, Cowan DJ, Gaul M, Glennon K, Lambert MH, et al. (2001) Design of selective and soluble inhibitors of tumor necrosis factor-α converting enzyme (TACE). J Med Chem 44:4252-4267.
309. Rahman I (2003) Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 36:95-109.
310. Rahman I, Morrison D, Donaldson K, and MacNee W (1996) Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 154:1055-1060.
311. Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, and de Boer WI (2002) 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:490-495.
312. Rao NV, Marshall BC, Gray BH, and Hoidal JR (1993) Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am J Respir Cell Mol Biol 8:612-616.
313. Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, and Hoidal JR (1991) Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 266:9540-9548.
314. Reader JR, Hyde DM, Schelegle ES, Aldrich MC, Stoddard AM, McLane MP, Levitt RC, and Tepper JS (2003) Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol 28:664-672.
315. Reddy VY, Zhang QY, and Weiss SJ (1995) Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 92:3849-3853.
316. Reibman J, Hsu Y, Chen LC, Bleck B, and Gordon T (2003) Airway epithelial cells release MIP-3α/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 28:648-654.
317. Repine JE, Bast A, and Lankhorst I (1997) Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:341-357.
318. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, and Hogg JC (2001) Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 164:469-473.
319. Rhoden KJ and Barnes PJ (1989) Effect of oxygen-derived free radicals on responses of guinea-pig tracheal smooth muscle in vitro. Br J Pharmacol 98:325-330.
320. Richards GA, Theron AJ, Van der Merwe CA, and Anderson R (1989) Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes. Am Rev Respir Dis 139:181-187.
321. Rogers DF, Aursudkij B, and Barnes PJ (1989) Effects of tachykinins on mucus secretion on human bronchi in vitro. Eur J Pharmacol 174:283-286.
322. Roland M, Bhowmik A, Sapsford RJ, Seemungal TA, Jeffries DJ, Warner TD, and Wedzicha JA (2001) Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 56:30-35.
323. Rooney CP, Taggart C, Coakley R, McElvaney NG, and O'Neill SJ (2001) Anti-proteinase 3 antibody activation of neutrophils can be inhibited by α1-antitrypsin. Am J Respir Cell Mol Biol 24:747-754.
324. Rose Jr CE, Sung SS, and Fu SM (2003) Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10:273-288.
325. Rossi D and Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242.
326. Rubinstein I, Kumar B, and Schriever C (2004) Long-term montelukast therapy in moderate to severe COPD - a preliminary observation. Respir Med 98:134-138.
327. Rupp J, Kothe H, Mueller A, Maass M, and Dalhoff K (2003) Imbalanced secretion of IL-1β and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients. Eur Respir J 22:274-279.
328. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, and Barnes PJ (2002a) Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26:602-609.
329. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, and Barnes PJ (2002b) Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine and serine proteases. Am J Physiol Lung Cell Mol Physiol 283:L867-L873.
330. Rusznak C, Devalia JL, Sapsford RJ, and Davies RJ (1996) Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur Respir J 9:2298-2305.
331. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, and Lozewicz S (2000) Effect of cigarette smoke on the permeability and IL-1β and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 23:530-536.
332. Rutgers SR, Van der Mark TW, Coers W, Moshage H, Timens W, Kauffman HF, Koeter GH, and Postma DS (1999) Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease [see comments]. Thorax 54:576-580.
333. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, et al. (1999) CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:711-717.
334. Saetta M, Distefano A, Maestrelli P, Graziella T, Rugieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, and Fabbri LM (1994) Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150:1646-1652.
335. Saetta M, Di Stefano A, Maestrelli P, Turato G, Mapp CE, Pieno M, Zanguochi G, Del Prete G, and Fabbri LM (1996) Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 26:766-774.
336. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:822-826.
337. Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, et al. (2002) Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 165:1404-1409.
338. Saetta M, Turato G, Maestrelli P, Mapp CE, and Fabbri LM (2001) Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1304-1309.
339. Sakao S, Tatsumi K, Hashimoto T, Igari H, Shino Y, Shirasawa H, and Kuriyama T (2003) Vascular endothelial growth factor and the risk of smoking-related COPD. Chest 124:323-327.
340. Sakao S, Tatsumi K, Igari H, Watanabe R, Shino Y, Shirasawa H, and Kuriyama T (2002) Association of tumor necrosis factor-α gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 122:416-420.
341. Sallenave JM (2000) The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 1:87-92.
342. Sallusto F and Lanzavecchia A (2000) Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177:134-140.
343. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R, Roca J, Rodriguez-Roisin R, and Barbera JA (2003) Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1250-1256.
344. Schulz C, Kratzel K, Wolf K, Schroll S, Kohler M, and Pfeifer M (2004) Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD. Chest 125:1706-1713.
345. Schulz C, Wolf K, Harth M, Kratzel K, Kunz-Schughart L, and Pfeifer M (2003) Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and never-smokers. Respiration 70:254-261.
346. Schunemann HJ, Freudenheim JL, and Grant BJ (2001) Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction. Epidemiol Rev 23:248-267.
347. 4 levels in patients with obstructive pulmonary disease. Chest 99:289-291.
348. Selman M, Cisneros-Lira J, Gaxiola M, Ramirez R, Kudlacz EM, Mitchell PG, and Pardo A (2003) Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs. Chest 123:1633-1641.
349. Senior RM, Tegner H, Kuhn C, Ohlsson K, Starcher BC, and Pierce JA (1977) The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis 116:469-475.
350. Shamsuddin M, Chen E, Anderson J, and Smith LJ (1997) Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages. J Lab Clin Med 130:615-626.
351. Shao MX, Nakanaga T, and Nadel JA (2004) Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-α converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol 287:L420-L427.
352. Shapiro SD (1999) The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:S29-S32.
353. Shapiro SD (2002) Neutrophil elastase: path clearer, pathogen killer, or just pathologic? Am J Respir Cell Mol Biol 26:266-268.
354. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, and Belaaouaj A (2003) Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163:2329-2335.
355. Shapiro SD and Senior RM (1999) Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 20:1100-1102.
356. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DC, and Nadel JA (2001) IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol 280:L134-L140.
357. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, Nicolaides NC, Holroyd KJ, Tsicopoulos A, Lafitte JJ, et al. (2000) IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 105:108-115.
358. 4 release in stimulated alveolar macrophages from asthmatic patients. Eur Respir J 11:1098-1104.
359. Sies H and Masumoto H (1997) Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol 38:229-246.
360. 4 receptor antagonist LY29311: in vivo pulmonary studies. Naunyn Schmiedebergs Arch Pharmacol 361:397-404.
361. Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, Vallone J, Faffe DS, Shikanai T, Raby BA, Weiss ST, et al. (2004) Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 169:214-219.
362. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, and Zaubet A (1999) Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 14:1015-1022.
363. Soler P, Moreau A, Basset F, and Hance AJ (1989) Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/ Langerhans cells. Am Rev Respir Dis 139:1112-1117.
364. Sommerhoff CP, Nadel JA, Basbaum CB, and Caughey GH (1990) Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Investig 85:682-689.
365. Song W, Zhao J, and Li Z (2001) Interleukin-6 in bronchoalveolar lavage fluid from patients with COPD. Chin Med J (Engl) 114:1140-1142.
366. Sparrow D, Glynn EJ, Cohen M, and Weiss ST (1984) The relationship of the peripheral leukocyte count and cigarette smoking to pulmonary function among adult men. Chest 86:383-386.
367. 2α on acetylcholine release from paraxympathetic nerves in guinea pig airways. Eur J Pharmacol 416:231-234.
368. 3-subtype. Br J Pharmacol 123:1246-1252.
369. Spiropoulos K, Trakada G, Nikolaou E, Prodromakis E, Efremidis G, Pouli A, and Koniavitou A (2003) Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Respir Med 97:983-989.
370. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, and Decramer M (2003) Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 58:752-756.
371. Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448-464.
372. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 51:267-271.
373. Stockley RA (2001) Proteases and antiproteases. Novartis Found Symp 234:189-199.
374. 2α on sensitivity of the human cough reflex. J Appl Physiol 73:649-653.
375. Strunk RC, Eidlen DM, and Mason RJ (1988) Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Investig 81:1419-1426.
376. Sugiura H, Ichinose M, Tomaki M, Ogawa H, Koarai A, Kitamuro T, Komaki Y, Akita T, Nishino H, Okamoto S, et al. (2004) Quantitative assessment of protein-bound tyrosine nitration in airway secretions from patients with inflammatory airway disease. Free Radic Res 38:49-57.
377. Sunyer J (2001) Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 17:1024-1033.
378. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, and Levine RL (2000) Oxidation of either methionine 351 or methionine 358 in α1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 275:27258-27265.
379. Taggart CC, Greene CM, McElvaney NG, and O'Neill S (2002) Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IκBα degradation without affecting phosphorylation or ubiquitination. J Biol Chem 277:33648-33653.
380. Taggart CC, Lowe GJ, Greene CM, Mulgrew AT, O'Neill SJ, Levine RL, and McElvaney NG (2001) Cathepsin B, L and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem 276:33345-33352.
381. Taha R, Olivenstein R, Utsumi T, Ernst P, Barnes PJ, Rodger IW, and Giaid A (2000) Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:636-640.
382. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K, and Okamura K (1999) Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 14:309-314.
383. Takeyabu K, Betsuyaku T, Nishimura M, Yoshioka A, Tanino M, Miyamoto K, and Kawakami Y (1998) Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J 12:1033-1039.
384. Takeyama K, Agusti C, Ueki I, Lausier J, Cardell LO, and Nadel JA (1998) Neutrophil-dependent goblet cell degranulation: role of membrane-bound elastase and adhesion molecules. Am J Physiol 275:L294-L302.
385. Takeyama K, Dabbagh K, Jeong SJ, Dao-Pick T, Ueki IF, and Nadel JA (2000) Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 164:1546-1552.
386. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, and Nadel JA (1999) Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96:3081-3086.
387. Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF, Protin U, Kroschel P, and Nadel JA (2001) Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol 280:L165-L172.
388. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, and Umeda A (2001) Increased expression of transforming growth factor-β1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 163:1476-1483.
389. Takubo Y, Guerassimov A, Ghezzo H, Triantafillopoulos A, Bates JH, Hoidal JR, and Cosio MG (2002) α1-Antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease. Am J Respir Crit Care Med 166:1596-1603.
390. Tamaoki J, Chiyotani A, Kobayashi S, Noritaka T, Kanemura T, and Takizawa T (1992) Effect of indomethacin on bronchorrhea with chronic bronchitis, diffuse panbronchiolitis or bronchiectasis. Am Rev Respir Dis 145:548-552.
391. Tamaoki J, Isono K, Takeyama K, Tagaya E, Nakata J, and Nagai A (2004) Ultrafine carbon black particles stimulate proliferation of human airway epithelium via EGF receptor-mediated signaling pathway. Am J Physiol, in press.
392. Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, and Nishimura M (2002) Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 57:405-411.
393. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, and Soler P (1999) Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. J Immunol 163:3511-3515.
394. Tazi A, Soler P, and Hance AJ (2000) Adult pulmonary Langerhans' cell histiocytosis. Thorax 55:405-416.
395. 10) by alveolar macrophages stimulates the release of polymorphonuclear leukocytes from bone marrow. Am J Respir Crit Care Med 155:1441-1447.
396. Tokuyama K, Kuo H-P, Rohde JAL, Barnes PJ, and Rogers DF (1990) Neural control of goblet cell secretion in guinea pig airways. Am J Physiol 259:L108-L115.
397. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, and Shirato K (1995) Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 151:613-617.
398. Tomita K, Barnes PJ, and Adcock IM (2003) The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 301:572-577.
399. Tomita K, Caramori G, Lim S, Ito K, Hanazawa T, Oates T, Chiselita I, Jazrawi E, Chung KF, Barnes PJ, et al. (2002) Increased p21CIP1/WAF1 and B cell lymphoma leukemia-xL expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 166:724-731.
400. Toossi Z, Hirsch CS, Hamilton BD, Knuth CK, Friedlander MA, and Rich EA (1996) Decreased production of TGF-β 1 by human alveolar macrophages compared with blood monocytes. J Immunol 156:3461-3468.
401. Trakada G, Marangos M, and Spiropoulos K (2001) Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhemoglobin desaturation. Respiration 68:134-139.
402. Traves SL, Culpitt S, Russell REK, Barnes PJ, and Donnelly LE (2002) Elevated levels of the chemokines GRO-α and MCP-1 in sputum samples from COPD patients. Thorax 57:590-595.
403. Traves SL, Smith SJ, Barnes PJ, and Donnelly LE (2004) Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol 76:441-450
404. 1 receptor in the mouse trachea and urinary bladder. Br J Pharmacol 126:1293-1300.
405. Tsukagoshi H, Haddad E-B, Barnes PJ, and Chung KF (1995) Bradykinin receptor subtypes in rat lung: effect of interleukin-1β. J Pharmacol Exp Ther 273:1257-1263.
406. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, and Flores SC (2003) Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 29:88-97.
407. Turato G, Zuin R, and Saetta M (2001) Pathogenesis and pathology of COPD. Respiration 68:117-128.
408. Turk V, Turk B, and Turk D (2001) Lysosomal cysteine proteases: facts and opportunities. EMBO (Eur Mol Biol Organ) J 20:4629-4633.
409. + T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 98:57-65.
410. Van Den Steen PE, Proost P, Wuyts A, Van Damme J, and Opdenakker G (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4 and GRO-α and leaves RANTES and MCP-2 intact. Blood 96:2673-2681.
411. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, van der Zee JS, Dentener MA, Wouters EF, and Verweij CL (2002) Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 3:436-439.
412. van der Vliet A, Eiserich JP, Shigenaga MK, and Cross CE (1999a) Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 160:1-9.
413. van der Vliet A, O'Neill CA, Cross CE, Koostra JM, Volz WG, Halliwell B, and Louie S (1999b) Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids. Am J Physiol 276:L289-L296.
414. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, and Henson PM (2002) Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Investig 109:661-670.
415. Vernooy JH, Kucukaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, and Wouters EF (2002) Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 166:1218-1224.
416. Vestbo J, Sorensen T, Lange P, Brix A, Torre P, and Viskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 353:1819-1823.
417. Vogelmeier C, Hubbard RC, Fells GA, Schnebli HP, Thompson RC, Fritz H, and Crystal RG (1991) Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Investig 87:482-488.
418. Voynow JA, Young LR, Wang Y, Borger T, Rose MC, and Fischer BM (1999) Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 276:L835-L843.
419. Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, and Kemeny DM (2000) Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 95:231-240.
420. Wagner PD (2003) Vascular endothelial growth factor and the pathogenesis of emphysema. Am J Med 114:413-414.
421. Wakeling AE (2002) Epidermal growth factor receptor tyrosine kinase inhibitors. Curr Opin Pharmacol 2:382-387.
422. Wallace AM and Sandford AJ (2002) Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease? Am J Pharmacogenomics 2:167-175.
423. Wang B, Cleary PP, Xu H, and Li JD (2003) Up-regulation of interleukin-8 by novel small cytoplasmic molecules of nontypeable Haemophilus influenzae via p38 and extracellular signal-regulated kinase pathways. Infect Immun 71:5523-5530.
424. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman Jr HA, Shapiro SD, and Elias JA (2000) Interferon γ induction of pulmonary emphysema in the adult murine lung. J Exp Med 192:1587-1600.
425. Ward PA (2004) The dark side of C5a in sepsis. Nat Rev Immunol 4:133-142.
426. Wark PA (2002) DX-890 (Dyax). IDrugs 5:586-589.
427. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, and Meade TW (2000) Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 84:210-215.
428. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, et al. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273:10095-10098.
429. Williams L, Bradley L, Smith A, and Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172:567-576.
430. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, and Tetley TD (2004) Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 30:500-509.
431. Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, Nusbaum P, Ueki I, Canteloup S, Lenoir G, Descamps-Latscha B, and Nadel JA (1999) Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol 20:729-736.
432. 4 and interleukin 8. Thorax 57:709-714.
433. Wright JL, Farmer SG, and Churg A (2002) Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs. Am J Respir Crit Care Med 166:954-960.
434. Wu L, Chau J, Young RP, Pokorny V, Mills GD, Hopkins R, McLean L, and Black PN (2004) Transforming growth factor-β1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 59:126-129.
435. Xanthoudakis S and Curran T (1996) Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv Exp Med Biol 387:69-75.
436. Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, and Narita N (1997) Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 112:505-510.
437. Yang XD, Corvalan JR, Wang P, Roy CM, and Davis CG (1999) Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states. J Leukoc Biol 66:401-410.
438. 4 receptor BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 192:421-432.
439. Yoshioka A, Betsuyaku T, Nishimura M, Miyamoto K, Kondo T, and Kawakami Y (1995) Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. Am J Respir Crit Care Med 152:2127-2132.
440. Yu Q and Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176.
441. Zeid NA and Muller HK (1995) Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 27:247-254.
442. Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, and Bessler H (2002) Immune response in asymptomatic smokers. Acta Anesthesiol Scand 46:959-964.
443. 2 and matrix metalloproteinases. J Clin Investig 88:894-900.
444. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese Jr RJ, Chapman Jr HA, Shapiro SD, and Elias JA (2000) Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Investig 106:1081-1093.
445. Zhu J, Qiu YS, Majumdar S, Gamble E, Matin D, Turato G, Fabbri LM, Barnes N, Saetta M, and Jeffery PK (2001) Exacerbations of bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5 and eosinophil chemoattractants. Am J Respir Crit Care Med 164:109-116.